TSS
CRL icon

Two Sigma Securities’s Charles River Laboratories CRL Stock Holding History

Two Sigma Securities’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-4,996
Closed -$758K – 1494
2025
Q2 		$758K Buy
4,996
+3,659
+274% +$488K 0.09% 275
2025
Q1 		$201K Sell
1,337
-644
-33% -$108K 0.03% 857
2024
Q4 		$366K Buy
+1,981
New +$382K 0.05% 532
2024
Q2 		– Sell
-951
Closed -$215K – 3085
2024
Q1 		$258K Buy
+951
New +$227K ﹤0.01% 2102
2023
Q1 		– Sell
-2,023
Closed -$458K – 2759
2022
Q4 		$441K Buy
2,023
+386
+24% +$84.3K 0.01% 1199
2022
Q3 		$322K Buy
1,637
+282
+21% +$60.9K 0.01% 1495
2022
Q2 		$290K Buy
+1,355
New +$331K 0.01% 1333
2022
Q1 		– Sell
-856
Closed -$264K – 2167
2021
Q4 		$323K Buy
+856
New +$333K 0.01% 759
2020
Q1 		– Sell
-2,061
Closed -$315K – 1504
2019
Q4 		$315K Buy
+2,061
New +$285K ﹤0.01% 1753
2019
Q1 		– Sell
-6,524
Closed -$857K – 1907
2018
Q4 		$738K Buy
+6,524
New +$817K 0.01% 784

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Securities's CRL Position: Q3 2025 in Review

Two Sigma Securities sold out of Charles River Laboratories (CRL) in Q3 2025, closing a stake of 4,996 shares — an estimated $758K sold.

Two Sigma Securities first reported a position in CRL in Q4 2018 and held it in 10 quarters. The position peaked at $758K in Q2 2025. 556 funds tracked by Wall St. Rank hold CRL as of Q3 2025.

  • Two Sigma Securities reported no remaining Charles River Laboratories position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 4,996 Charles River Laboratories shares in Q3 2025, an estimated $758K.
  • Two Sigma Securities first reported a position in Charles River Laboratories in Q4 2018 and held it in 10 quarters.
  • Two Sigma Securities's Charles River Laboratories position peaked at $758K in Q2 2025.
  • 556 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.